Consort Medical PLC Director/PDMR Shareholding (7668I)
June 21 2017 - 6:09AM
UK Regulatory
TIDMCSRT
RNS Number : 7668I
Consort Medical PLC
21 June 2017
21 June 2017
Consort Medical plc
Notification of Transactions of Directors or
Persons Discharging Managerial Responsibility and Connected
Persons
On 20 June 2017 pursuant to the rules of the Consort Medical plc
Performance Share Plan the following Directors/persons discharging
managerial responsibilities ("PDMRs") of Consort Medical plc (the
"Company"), were granted awards over ordinary shares at a share
price of GBP10.67 ("Shares") in the Company as detailed against
their name below:
Performance Share Plan Award
Director/PDMR Number of
Shares
------------------ ----------
Jon Glenn 45,385
------------------ ----------
Paul Hayes 29,990
------------------ ----------
Keyvan Djamarani 16,869
------------------ ----------
Manja Boerman 16,869
------------------ ----------
Each award was granted as a nil cost option.
Enquiries: Michelle Palmer Assistant Company Secertary 01442 867920
Consort Medical plc is a leading, global, single source pharma
services drug and delivery device company. We are at the leading
edge of innovation and we are committed to investing in patient,
clinician and customer driven innovation to create new treatments,
new markets and new opportunities.
Our businesses
Bespak is a global market leader in the manufacture of drug
delivery devices for pharmaceutical partner companies, including
respiratory, nasal, injectables and ocular products, and the
manufacture of devices for the point of care diagnostics market.
www.bespak.com.
Aesica is a leading provider of finished dose and active
pharmaceutical ingredient (API) development and manufacturing
services to pharmaceutical partners. www.aesica-pharma.com.
We employ more than 2000 people globally of which 1400 are
located in the UK. We have UK facilities in King's Lynn, Cambridge,
Nelson, Milton Keynes, Cramlington, Queenborough and Hemel
Hempstead, German facilities in Monheim and Zwickau and a facility
in Pianezza, Italy. Consort Medical is a public company quoted on
the premium list of the London Stock Exchange (LSE: CSRT).
www.consortmedical.com
1 Details of the person discharging managerial
responsibilities / person closely associated
---- ----------------------------------------------------------------------
a) Name Jonathan Glenn
---- ------------------------------ --------------------------------------
2 Reason for the notification
---- ----------------------------------------------------------------------
a) Position/status CEO
---- ------------------------------ --------------------------------------
b) Initial notification Initial notification
/Amendment
---- ------------------------------ --------------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------
a) Name Consort Medical plc
---- ------------------------------ --------------------------------------
b) LEI 2138001TBP74FD66QT38
---- ------------------------------ --------------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
---- ----------------------------------------------------------------------
a) Description of Ordinary 10p shares
the financial
instrument, type
of instrument
----
Identification ISIN: GB0000946276
code
b) Nature of the Grant of ordinary shares
transaction pursuant to the Consort Medical
Performance Share Plan
---- ------------------------------ --------------------------------------
c) Price(s) and volume(s)
---- ---------------- -----------------
Price(s) Volume(s)
---- ---------------- -----------------
0 45,385
---------------- -----------------
d) Aggregated information n/a single transaction
----
- Aggregated volume
- Price
e) Date of the transaction 20 June 2017
---- ------------------------------ --------------------------------------
f) Place of the transaction Off market transaction
---- ------------------------------ --------------------------------------
1 Details of the person discharging managerial
responsibilities / person closely associated
---- ----------------------------------------------------------------------
a) Name Paul Hayes
---- ------------------------------ --------------------------------------
2 Reason for the notification
---- ----------------------------------------------------------------------
a) Position/status CFO
---- ------------------------------ --------------------------------------
b) Initial notification Initial notification
/Amendment
---- ------------------------------ --------------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------
a) Name Consort Medical plc
---- ------------------------------ --------------------------------------
b) LEI 2138001TBP74FD66QT38
---- ------------------------------ --------------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
---- ----------------------------------------------------------------------
a) Description of Ordinary 10p shares
the financial
instrument, type
of instrument
----
Identification ISIN: GB0000946276
code
b) Nature of the Grant of ordinary shares
transaction pursuant to the Consort Medical
Performance Share Plan
---- ------------------------------ --------------------------------------
c) Price(s) and volume(s)
---- ---------------- -----------------
Price(s) Volume(s)
---- ---------------- -----------------
0 29,990
---------------- -----------------
d) Aggregated information n/a single transaction
----
- Aggregated volume
- Price
e) Date of the transaction 20 June 2017
---- ------------------------------ --------------------------------------
f) Place of the transaction Off market transaction
---- ------------------------------ --------------------------------------
1 Details of the person discharging managerial
responsibilities / person closely associated
---- ----------------------------------------------------------------------
a) Name Keyvan Djamarani
---- ------------------------------ --------------------------------------
2 Reason for the notification
---- ----------------------------------------------------------------------
a) Position/status Managing Director Bespak
Division
---- ------------------------------ --------------------------------------
b) Initial notification Initial notification
/Amendment
---- ------------------------------ --------------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------
a) Name Consort Medical plc
---- ------------------------------ --------------------------------------
b) LEI 2138001TBP74FD66QT38
---- ------------------------------ --------------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
---- ----------------------------------------------------------------------
a) Description of Ordinary 10p shares
the financial
instrument, type
of instrument
----
Identification ISIN: GB0000946276
code
b) Nature of the Grant of ordinary shares
transaction pursuant to the Consort Medical
Performance Share Plan
---- ------------------------------ --------------------------------------
c) Price(s) and volume(s)
---- ---------------- -----------------
Price(s) Volume(s)
---- ---------------- -----------------
0 16,869
---------------- -----------------
d) Aggregated information n/a single transaction
----
- Aggregated volume
- Price
e) Date of the transaction 20 June 2017
---- ------------------------------ --------------------------------------
f) Place of the transaction Off market transaction
---- ------------------------------ --------------------------------------
1 Details of the person discharging managerial
responsibilities / person closely associated
---- ----------------------------------------------------------------------
a) Name Manja Boerman
---- ------------------------------ --------------------------------------
2 Reason for the notification
---- ----------------------------------------------------------------------
a) Position/status Manging Director Aesica Division
---- ------------------------------ --------------------------------------
b) Initial notification Initial notification
/Amendment
---- ------------------------------ --------------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------
a) Name Consort Medical plc
---- ------------------------------ --------------------------------------
b) LEI 2138001TBP74FD66QT38
---- ------------------------------ --------------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
---- ----------------------------------------------------------------------
a) Description of Ordinary 10p shares
the financial
instrument, type
of instrument
----
Identification ISIN: GB0000946276
code
b) Nature of the Grant of ordinary shares
transaction pursuant to the Consort Medical
Performance Share Plan
---- ------------------------------ --------------------------------------
c) Price(s) and volume(s)
---- ---------------- -----------------
Price(s) Volume(s)
---- ---------------- -----------------
0 16,869
---------------- -----------------
d) Aggregated information n/a single transaction
----
- Aggregated volume
- Price
e) Date of the transaction 20 June 2017
---- ------------------------------ --------------------------------------
f) Place of the transaction Off market transaction
---- ------------------------------ --------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHFFLFLDQFBBBD
(END) Dow Jones Newswires
June 21, 2017 07:09 ET (11:09 GMT)
Consort Medical (LSE:CSRT)
Historical Stock Chart
From Apr 2024 to May 2024
Consort Medical (LSE:CSRT)
Historical Stock Chart
From May 2023 to May 2024